AUPH vs POOL · P/E 28, rev $283.1M vs P/E 18, rev $5.31B
Aurinia Pharmaceuticals Inc (AUPH) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported AUPH revenue for 2025-12-31 was $283.1M. Net income was $287.2M. Revenue was up 372.8% from 2024-12-31 to 2025-12-31. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the AUPH and POOL stock pages for the full models.
Not investment advice.